[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2011157609A3 - Use of amino acid derivatives as agents for treating human perspiration, peptide derivatives, and compositions containing them - Google Patents

Use of amino acid derivatives as agents for treating human perspiration, peptide derivatives, and compositions containing them Download PDF

Info

Publication number
WO2011157609A3
WO2011157609A3 PCT/EP2011/059530 EP2011059530W WO2011157609A3 WO 2011157609 A3 WO2011157609 A3 WO 2011157609A3 EP 2011059530 W EP2011059530 W EP 2011059530W WO 2011157609 A3 WO2011157609 A3 WO 2011157609A3
Authority
WO
WIPO (PCT)
Prior art keywords
amino acid
agents
compositions containing
acid derivatives
human perspiration
Prior art date
Application number
PCT/EP2011/059530
Other languages
French (fr)
Other versions
WO2011157609A2 (en
Inventor
Maria Dalko
José Cotovio
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Publication of WO2011157609A2 publication Critical patent/WO2011157609A2/en
Publication of WO2011157609A3 publication Critical patent/WO2011157609A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to the use of amino acid derivatives corresponding to formula (I) below: in which: AA is a peptide sequence composed of 1 to 12 amino acid chosen from the following: with n = 1, 2, 3 as agents for treating human perspiration in a cosmetic composition. The invention also relates to a cosmetic process for treating perspiration and possibly the body odour associated with human perspiration, especially underarm odour. The invention also relates to novel amino acid derivatives and to cosmetic or dermatological compositions containing them.
PCT/EP2011/059530 2010-06-17 2011-06-08 Use of amino acid derivatives as agents for treating human perspiration, novel compounds, and compositions containing them WO2011157609A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR1054802A FR2961392A1 (en) 2010-06-17 2010-06-17 USE OF AMINO ACID DERIVATIVES AS A TREATMENT AGENT FOR HUMAN PERSPIRATION; NEW COMPOUNDS; COMPOSITIONS CONTAINING THEM
FR1054802 2010-06-17
US35738910P 2010-06-22 2010-06-22
US61/357,389 2010-06-22

Publications (2)

Publication Number Publication Date
WO2011157609A2 WO2011157609A2 (en) 2011-12-22
WO2011157609A3 true WO2011157609A3 (en) 2012-03-15

Family

ID=43502956

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/059530 WO2011157609A2 (en) 2010-06-17 2011-06-08 Use of amino acid derivatives as agents for treating human perspiration, novel compounds, and compositions containing them

Country Status (2)

Country Link
FR (1) FR2961392A1 (en)
WO (1) WO2011157609A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014216917A1 (en) * 2014-08-26 2016-03-03 Henkel Ag & Co. Kgaa Antiperspirant cosmetic products with special design proteins which do not contain halides and / or hydroxy halides of aluminum and / or zirconium
CN104649929B (en) * 2015-02-13 2016-03-23 山东省食品药品检验研究院 The preparation method of 4-(N-(4-aminobutanonyl))-aminobutyric acid and application
FR3119321A1 (en) * 2021-02-04 2022-08-05 L'oreal Cosmetic powder for the prevention and/or treatment of perspiration and associated composition

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0467856A2 (en) * 1990-07-19 1992-01-22 Nippon Zoki Pharmaceutical Co. Ltd. Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases
WO2003059308A1 (en) * 2002-01-18 2003-07-24 Unilever Plc Antiperspirant compositions
WO2004026295A2 (en) * 2002-09-17 2004-04-01 Phenion Gmbh & Co. Kg Use of skin-protecting substances
WO2007068401A1 (en) * 2005-12-16 2007-06-21 Unilever Plc Hair treatment compositions
US20080095732A1 (en) * 2005-04-27 2008-04-24 Rosemarie Osborne Personal care compositions
WO2008049042A2 (en) * 2006-10-18 2008-04-24 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
GB2463362A (en) * 2008-09-12 2010-03-17 Yoshiharu Masui Antibacterial deodorant comprising at least one of glycine, c ysteine or glycylglycine and mixtures thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792068A (en) 1971-04-02 1974-02-12 Procter & Gamble Dry powder aerosol antiperspirant composition incorporating dry powder antiperspirant active complex and process for its preparation
FR2668080B1 (en) 1990-10-17 1993-08-13 Seppic Sa SELF-EMULSIONABLE COMPOSITIONS BASED ON FATTY ALCOHOLS, THEIR PREPARATION PROCESS AND THEIR USE FOR MAKING EMULSIONS.
FR2712595B1 (en) 1993-11-19 1995-12-22 Seppic Sa A concentrate comprising alkyl glycosides and its uses.
US5874069A (en) 1997-01-24 1999-02-23 Colgate-Palmolive Company Cosmetic composition containing silicon-modified amides as thickening agents and method of forming same
US5919441A (en) 1996-04-01 1999-07-06 Colgate-Palmolive Company Cosmetic composition containing thickening agent of siloxane polymer with hydrogen-bonding groups
US5783657A (en) 1996-10-18 1998-07-21 Union Camp Corporation Ester-terminated polyamides of polymerized fatty acids useful in formulating transparent gels in low polarity liquids
FR2756176B1 (en) 1996-11-26 1998-12-18 Oreal COSMETIC COMPOSITION COMPRISING A FLUORINATED COMPOUND AND HAVING IMPROVED COMFORT
FR2762317B1 (en) 1997-04-21 1999-07-09 Seppic Sa COMPOSITION BASED ON ALKYLPOLYGLYCOSIDES AND FATTY ALCOHOLS AND USES THEREOF
US6051216A (en) 1997-08-01 2000-04-18 Colgate-Palmolive Company Cosmetic composition containing siloxane based polyamides as thickening agents
US5981680A (en) 1998-07-13 1999-11-09 Dow Corning Corporation Method of making siloxane-based polyamides
FR2792190B1 (en) 1999-04-16 2001-09-28 Sophim PROCESS FOR THE MANUFACTURE OF A NON-FATTY EMOLLIENT BASED ON WAX-ESTERS
WO2002047619A2 (en) 2000-12-12 2002-06-20 L'oreal S.A. Cosmetic composition comprising a polymer and fibres
WO2002056847A1 (en) 2001-01-17 2002-07-25 L'oreal Cosmetic composition comprising a polymer and a fluorinated oil
ZA200707351B (en) 2005-03-03 2010-02-24 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of an oligopeptide
EP1798213A1 (en) 2005-12-14 2007-06-20 Cognis IP Management GmbH Process for the production of hydrocarbons
WO2010003781A1 (en) 2008-07-08 2010-01-14 Unilever Plc Antiperspirant compositions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0467856A2 (en) * 1990-07-19 1992-01-22 Nippon Zoki Pharmaceutical Co. Ltd. Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases
WO2003059308A1 (en) * 2002-01-18 2003-07-24 Unilever Plc Antiperspirant compositions
WO2004026295A2 (en) * 2002-09-17 2004-04-01 Phenion Gmbh & Co. Kg Use of skin-protecting substances
US20080095732A1 (en) * 2005-04-27 2008-04-24 Rosemarie Osborne Personal care compositions
WO2007068401A1 (en) * 2005-12-16 2007-06-21 Unilever Plc Hair treatment compositions
WO2008049042A2 (en) * 2006-10-18 2008-04-24 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
GB2463362A (en) * 2008-09-12 2010-03-17 Yoshiharu Masui Antibacterial deodorant comprising at least one of glycine, c ysteine or glycylglycine and mixtures thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
C. GARRIGOU-LAGRANGE, H. JENSEN, M. COTRAIT: "Étude cristallographique et vibrationnelle de la glycyltaurine", JOURNAL OF MOLECULAR STRUCTUTRE, vol. 36, no. 2, February 1977 (1977-02-01), pages 275 - 287, XP002620716, DOI: 10.1016/0022-2860(77)85061-8 *
RALPH LIVINGSTON, DAVID G. DOHERTY, HENRY ZELDES: "Electron spin resonance study of liquids during photolysis. XIX. Aliphatic dipeptides", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 97, no. 11, 28 May 1975 (1975-05-28), pages 3198 - 3204, XP002620715, DOI: 10.1021/ja00844a046 *
TSUNEYOSHI Y ET AL: "Reverse structure of carnosine-induced sedative and hypnotic effects in the chick under acute stress", LIFE SCIENCES, PERGAMON PRESS, OXFORD, GB, vol. 82, no. 21-22, 23 May 2008 (2008-05-23), pages 1065 - 1069, XP022648477, ISSN: 0024-3205, [retrieved on 20080403], DOI: DOI:10.1016/J.LFS.2008.03.015 *

Also Published As

Publication number Publication date
FR2961392A1 (en) 2011-12-23
WO2011157609A2 (en) 2011-12-22

Similar Documents

Publication Publication Date Title
PH12019500644A1 (en) Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
WO2009080306A8 (en) Anti-dandruff compositions containing peptides
MX2010003258A (en) Use of a novel natural agent in cosmetic compositions.
TW200716661A (en) A novel triterpenic acid derivative and the skin external preparation containing the same
WO2009017369A3 (en) Compositions for skin protection and improvement of skin diseases containing the dibenzo-p-dioxine derivatives
MX337830B (en) Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions.
MX341211B (en) Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions.
WO2013061004A8 (en) Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
WO2013006335A3 (en) Methods and compositions useful for treating fitzpatrick type iv, v or vi skin
WO2012076109A3 (en) 2-pyrones
WO2008107092A3 (en) Use of derivatives of 4-hydroxyphenoxy acetic acid
IN2011KN05169A (en)
WO2010117709A3 (en) Peptide-based systems for delivery of costmetic agents
WO2010082176A3 (en) Compositions containing kxk type peptides
MX2014003449A (en) Heterocyclocarbonylaminothiazoles, cosmetic or dermatological preparations containing said heterocyclocarbonylaminothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin.
WO2011157609A3 (en) Use of amino acid derivatives as agents for treating human perspiration, peptide derivatives, and compositions containing them
WO2010119997A1 (en) Peptide having activity of transforming growth factor and production method therefor
MX2011007108A (en) Stroke-generated angiogenesis enhancers and uses thereof.
WO2011113785A3 (en) A cosmetic composition for rejuvenating skin appearance
WO2011015758A3 (en) Use of isoleucine n-hexadecanoyl as a "volumizing" and/or "plumping" agent for human skin
MX2009012714A (en) Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology.
MX2009012712A (en) Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology.
WO2010089421A3 (en) Menthyl carbamate compounds as active anti-cellulite ingredients
WO2014048868A3 (en) Hair dyeing process using at least one ortho-methoxyphenol, a manganese or zinc salt, hydrogen peroxide and (bi)carbonate
AU2017221784B2 (en) Novel compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11724207

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11724207

Country of ref document: EP

Kind code of ref document: A2